Request Deal Involvement

Ally Bridge led a $140m Series B round in Shoreline Biosciences.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Juniper Point

pr advisors

Juniper Point

Morrison Foerster

legal advisors

Morrison Foerster

or

Principals

EVENTIDE ASSET MANAGEMENT

bidder

EVENTIDE ASSET MANAGEMENT

KINGDON CAPITAL

bidder

KINGDON CAPITAL

BVF PARTNERS

bidder

BVF PARTNERS

SUPERSTRING CAPITAL

bidder

SUPERSTRING CAPITAL

SHORELINE BIOSCIENCES

target

SHORELINE BIOSCIENCES

ALLY BRIDGE GROUP

bidder

ALLY BRIDGE GROUP

NS INVESTMENT

bidder

NS INVESTMENT

PIPER HEARTLAND HEALTHCARE CAPITAL

bidder

PIPER HEARTLAND HEALTHCARE CAPITAL

LP FIRST CAPITAL

bidder

LP FIRST CAPITAL

JANUS HENDERSON INVESTORS

bidder

JANUS HENDERSON INVESTORS

KITE REALTY GROUP TRUST

bidder

KITE REALTY GROUP TRUST

STORK CAPITAL

bidder

STORK CAPITAL

BEIGENE LTD

bidder

BEIGENE LTD

GILEAD SCIENCES

bidder

GILEAD SCIENCES

IRVING INVESTORS

bidder

IRVING INVESTORS

COMMODORE CAPITAL

bidder

COMMODORE CAPITAL

WEDBUSH INC

bidder

WEDBUSH INC

BOXER CAPITAL

bidder

BOXER CAPITAL

CORMORANT ASSET MANAGEMENT

bidder

CORMORANT ASSET MANAGEMENT

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Ally Bridge led a $140m Series B round in Shoreline Biosciences.